Fibrin glue in managing intractable gingival bleeding in patients with inherited bleeding disorders-a quasi-experimental pilot study
Document Type
Article
Department
Community Health Sciences; Pathology and Laboratory Medicine
Abstract
This study presents the clinical outcomes of using inhouse prepared fibrin glue for controlling gingival bleeding in patients with inherited bleeding disorders (IBD). The objective of the study was to assess the reduction in transfusion days and improvement in compliance for dental evaluation over a one-year period in a low-to-middle-income country. The quasiexperimental pilot study included 40 IBD patients with gingival bleeding. These were divided into two groups: Group A received fibrin glue (n=20), while Group B did not (n=20). The study compared outcome metrics, including the number of treatment days and blood components transfused, using non-parametric tests with a significance threshold of p<0.05. Results showed that Group A required fewer blood components (n=154) as compared to Group B (n=204) (p<0.001). Patients in Group A with Glanzmann thrombasthenia (GT) had a shorter treatment duration (one day) than those in group B (three days) (p<0.01). In conclusion, the application of fibrin glue effectively managed intractable gingival bleeding in IBD patients.
Publication (Name of Journal)
Journal of the Pakistan Medical Association
DOI
10.47391/JPMA.9378
Recommended Citation
Hussain, S.,
Zaidi, S. A.,
Sawani, S.,
Moiz, B.
(2024). Fibrin glue in managing intractable gingival bleeding in patients with inherited bleeding disorders-a quasi-experimental pilot study. Journal of the Pakistan Medical Association, 74(2), 378-383.
Available at:
https://ecommons.aku.edu/pakistan_fhs_mc_chs_chs/1139